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509 
Organ Donations: Why the Gift of Life Ideology 
Is Losing Lives 
 




As people around the world continue to die on organ transplant waiting 
lists, the international community sits idly by, hoping that human kindness 
will solve the growing need for organs.  Current altruistic systems have 
proven to be inadequate to close the gap between the high demand for organs 
and the limited supply of legally available organs.  The international 
community’s aversion toward legal organ sales and the current issues 
stemming from the illegal organ market continue to impede progress toward 
saving lives.  However, some nations have begun to transition from strictly 
altruistic organ transplantation systems.  One example of a non-altruistic 
organ system is found in Iran, which has eliminated the nation’s kidney 
transplant waiting list by creating a government regulated commercial 
organ market.  The United States, which is being ravaged by a nationwide 
organ shortage, may feasibly be the next country to end its prohibition 
against compensating organ providers.  As the number of deaths due to lack 
of available organs continues to increase annually around the world, 
changes are essential and inevitable.  Organ donations should be seen as 
more than gifts of human kindness.  By barring compensation for organ 
providers, the international community violates the autonomy of willing 
donors and sentences thousands of patients to death.   
 
I. INTRODUCTION TO THE GLOBAL ORGAN SHORTAGE 
 
The World Health Organization (WHO) strongly supports altruistic 
systems for organ donations, and nearly all nations have adopted laws 
prohibiting the sale of organs.1  The current system of organ transplantation 
 
 1. World Health Organization [WHO], WHO Guiding Principles on Human Cell, Tissue 
and Organ Transplantation, at 5, Res. WHA63.22 (2010), http://www.who.int/transplantat 
ion/Guiding_PrinciplesTransplantation_WHA63.22en.pdf.  
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implemented by most nations is confined to the use of cadavers and altruistic 
donations from live donors.  Voluntary donations are available for patients 
lucky enough to survive the wait for anonymous donors, or for patients who 
have families or close friends willing to risk undergoing surgery.  Living 
donations are selfless acts of compassion, and in a perfect world, such 
altruistic deeds would be sufficient to meet the global demand for organ 
transplantations.  Unfortunately, the number of living donors does not come 
close to meeting the current demand for organs, and strict adherence to 
altruistic based policies has led to a severe organ deficit around the world. 
The demand for organs far outpaces the supply available for 
transplantation.  Of the 34,769 organ transplantations performed in the 
United States in 2017, less than eighteen percent came from living donors.2  
Most organ transplants involve organs taken from the dead.  Over ninety 
percent of transplants performed in China and the European Union stem from 
cadavers.3  Most patients cannot acquire an organ transplant through a living 
donor and must wait for one to become available.  Patients waiting for an 
organ transplant are stuck in the morbid position of hoping others die so they 
may use their organs or praying that others in the same dire position on the 
waiting list die before them, putting them one person closer to receiving life-
saving treatment.  
Proposals for legal organ markets have historically been rejected due to 
ethical concerns and fear of potential exploitation.  Altruistic transplant 
systems hold that organ donations should remain gifts and not involve 
financial compensation. 4   The global prohibition on financially 
compensating organ donors overlooks the most important fact: people are 
dying despite the ability to save them.  Altruistic donations alone are not 
sufficient to meet the growing demand, and the international community 
needs to consider commercial solutions to solve the organ crisis.  Patients 
should have access to organs they desperately need, and potential organ 
providers should have the option to seek compensation for their organs.   
 
 2. Organ Procurement & Transplantation Network, HEALTH RES. AND SERV. ADMIN., 
https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/# (last visited Mar. 20, 
2018). 
 3. Alex H. Jingwei et al., Living Organ Transplantation Policy Transition in Asia: 
Towards Adaptive Policy Changes, 3 GLOB. HEALTH GOVERNANCE 1 (June 2010). 
 4. Steve P. Calandrillo, Cash for Kidneys? Utilizing Incentives to End America's Organ 
Shortage, 13 GEO. MASON L. REV. 69, 99 (2004). 
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A. The Organ Crisis by the Numbers 
 
Medical advancements in the past few decades have caused a rise in the 
number of organ transplants performed globally each year.  In 2015, over 
126,000 transplants occurred worldwide, a 5.8 percent increase from the 
previous year.5  However, despite the growth in transplants, the number of 
patients who need an organ transplant continues to escalate at a faster rate.  
A recent report by the European Parliament’s Subcommittee on Human 
Rights estimated that only fifteen percent of patients on transplant waiting 
lists around the world receive the operation they need.6  Other reports paint 
an even bleaker picture.  The Global Observatory on Donation and 
Transplantation, an organization created through the joint efforts of the 
WHO, the Spanish Transplant Organization, the Council of Europe, and 
others, estimated that less than ten percent of the global need for organ 
transplants was met in 2015.7   
In the United States alone, over 115,000 people are currently on the 
national organ transplant waiting list.8  Even though ninety-two transplant 
surgeries are performed in the United States every day, deaths continue to 
climb as one patient is added to the national waiting list every ten minutes.9  
In 2017, 5,823 patients died while waiting for an organ to become 
available.10  In addition to the patient deaths, 6,770 patients were removed 
from the waiting list because they became too sick to qualify for a 
transplant.11  These fatalities are not unique to the United States.  In 2013, 
the European Union, including patients in Turkey, Iceland, and Norway, had 
an organ waiting list of around 86,000 people, and in the same year, around 
6,000 people died waiting for an organ.12  The organ situation seems bleakest 
in Asia, where cultural and educational obstacles have resulted in 
 
 5. Organ Donation and Transplantation Activities 2015, GLOB. OBSERVATORY ON 
DONATION & TRANSPLANTATION (2018), http://www.transplant-observatory.org/download/ 
2015-activity-data/. 
 6. European Parliament, Directorate-General for External Policies, Trafficking In 
Human Organs 16 (2015), http://www.europarl.europa.eu/RegData/etudes/STUD/2015/549 
055/EXPO_STU%282015%29549055_EN.pdf.  
 7. Organ Donation and Transplantation Activities 2015, supra note 5. 
 8. Organ Procurement & Transplantation Network, supra note 2 (last visited Mar. 20, 
2018). 
 9. Id. 
 10. Id. 
 11. Id. 
 12. Journalist Workshop on Organ Donations and Transplantation: Recent Facts & 
Figures, EUROPEAN COMMISSION (Nov. 26, 2014), https://ec.europa.eu/health/sites/health/ 
files/blood_tissues_organs/docs/ev_20141126_factsfigures_en.pdf.  
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significantly fewer organ donations than Western countries.13  In China there 
were an estimated 1.5 million patients listed on the national organ registry in 
2007, and in Taiwan, with nearly 6,500 patients on the transplant list, there 
were only 100 organ donations in 2008. 14   Time is a luxury for those 
suffering from organ failure, and holding on to exclusively altruistic organ 
policies will cause the number of fatalities to continue to increase. 
 
B. Current Policies Against the Sale of Organs 
 
Due to a variety of factors — history, culture, political ideologies, 
demographics, and geography — the international community rarely agrees 
on a uniform policy or practice.  Organ sales are the exception — they are 
banned in all countries but one: Iran.  Iran is the only nation in the world that 
allows organs to be bought and sold in a regulated commercial market.15  
Although other countries, like Saudi Arabia, Australia, and Singapore have 
government reimbursement programs to help compensate living donors for 
medical expenses and lost wages, commercial organ transactions are 
prohibited.16   
The rest of the world has created and adopted individual national 
policies that prohibit the commercialization of human organs and ban any 
form of monetary compensation to organ providers.  The WHO has been 
adamant about banning the sale of organs, and published the “Guiding 
Principles on Human Cell, Tissue and Organ Transplantation” in 1991.17  
These principles were created to provide nations with “an orderly, ethical 
and acceptable framework for the acquisition and transplantation of human 
cells, tissues and organs for therapeutic purposes.”18  In response to the 
shortage of legally available organs, the WHO revised their guiding 
principles on organ transplantation in 2010, but its stance against financial 
incentives remained unchanged.19  The WHO declared, “[c]ells, tissues and 
 
 13. Jingwei, supra note 3, at 4.  
 14. Id. at 4, 7.  
 15. Ahad J. Ghods & Shekoufeh Savaj, Iranian Model of Paid and Regulated Living-
Unrelated Kidney Donation, 1 CLIN. J. AM. SOC. NEPHROL 1136, 1137 (2006).   
 16. Jia L. Chong, Policy Options for Increasing the Supply of Transplantable Kidneys in 
Singapore, 57 SING. MED. J. 530, 531 (2016); Paul Garwood, Dilemma Over Live-Donor 
Transplantation, 85 BULLETIN OF THE WORLD HEALTH ORG. 1 (2007).   
 17. WHO, supra note 1. 
 18. Id. at 1.  
 19. Id.   
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organs should only be donated freely, without any monetary payment or 
other reward of monetary value.”20   
Laws banning and criminalizing the sale of organs began to develop 
once organ transplantation became a safer medical procedure in the late 
1980s.21  For many years, live kidney donations were only allowed to come 
from donors who were genetically related to the donee.22  In the last thirty 
years, statutes have adapted to the growing need for organ transplants by 
expanding the pool of potential donors to encompass spouses, friends, 
acquaintances, and even anonymous donors.23  Unfortunately, increasing the 
pool of potential donors has not solved the problem because far more organs 
are still needed. 
The rising death toll and increasing need for more available organs is 
causing people to reconsider the effectiveness of a purely altruistic organ 
transplant system.  Even the WHO acknowledges the shortcomings of the 
current system.  The WHO’s revised Guiding Principles report admitted, 
“[c]ontinuous improvements in medical technology . . . have led to an 
increase in the demand for organs and tissues, which has always exceeded 
supply despite substantial expansion in deceased organ donations as well as 
greater reliance on donation from living persons in recent years.”24  Despite 
the mounting data, the issue of whether to provide organ donors with 
financial incentives is still hotly contested.  
 
II. The Debate Surrounding Altruistic Organ Transplantations 
 
There are two primary arguments for maintaining an exclusive altruistic 
organ donation system, and both stem from the belief that allowing for-profit 
organ donations means treating the human body as a commodity.  The ethical 
argument is straightforward: the sale of human body parts is barbaric and has 
no place in civilized society.  The second argument against organ sales is 
more complex, revolving around the belief that legalizing financial 
compensation for organ providers will lead to the exploitation of the most 
marginalized and poorest people in the world.  The concern is that poor 
 
 20. Id. at 5.  
 21. United Nations Office on Drugs And Crime (UNODC), Trafficking in Persons for 
the Purpose of Organ Removal 7 (2015), http://www.unodc.org/documents/human-traffick 
ing/2015/UNODC_Assessment_Toolkit_TIP_for_the_Purpose_of_Organ_Removal.pdf. 
 22. Id. at 8. 
 23. Id.  
 24. WHO, supra note 1, at 1. 
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people, desperate to escape crippling poverty, would be taken advantage of 
by wealthy buyers.   
The arguments against a legal organ market fail to acknowledge the 
gravity of the current organ shortage.  The ethical questions are based on 
social norms, not reason.  The fear of increasing organ trafficking and other 
criminal activity involving the sale of organs is shortsighted.  The current 
illegal organ market is already causing an influx of transplantation crimes, 
and only shifts in policy, and strict regulation, can help alleviate the abuses 
of the black market. 
 
A. The Ethical Argument for Altruism 
 
The ethical argument against compensating organ providers is rooted in 
ideology, not in a reasoned argument.  People are naturally repulsed by the 
thought of someone selling their body, so their flesh can be used by another, 
and it is easy to lump the sale of organs in with other cultural taboos like 
necrophilia, cannibalism, and the defiling of corpses.25  The economic and 
societal value of legitimizing an organ market is overshadowed by society’s 
revulsion toward the act of paying for an organ, and falls outside the 
acceptable scope of commerce.  Even Margret Thatcher, the former prime 
minister of the United Kingdom and a firm believer and advocate for the free 
market, said “the sale of kidneys or any organs of the body is utterly 
repugnant.”26   
Leon Kass, an oft-published and outspoken American scientist, 
described this connection with the human body as “psychophysical unity,” 
which “regards a human being as largely, if not wholly, self-identical with 
his enlivened body.”27  The human body is what makes someone a human 
being; the identity of being “human” is tied to the body.  From this 
perspective, Kass theorized that “organ transplantation . . . is — once we 
strip away the trappings of the sterile operating rooms and their astonishing 
technologies — simply a noble form of cannibalism.”28  Under this ideology, 
organ transactions are seen as desecrating the human body, and an attack on 
what makes us human. 
The stigma surrounding the commercialization of the human body 
paints the sale of one’s organs as nothing more than a dressed-up act of 
 
 25. LEON R. KASS, LIFE, LIBERTY, AND THE DEFENSE OF DIGNITY: THE CHALLENGE FOR 
BIOETHICS 183 (2002). 
 26. Michael Kinsley, Take My Kidney, Please, TIME, Mar. 13, 1989, at 88. 
 27. KASS, supra note 25, at 81-82, 185. 
 28. Id. at 185. 
   
Summer 2019]          Organ Donations: Why the Gift of Life Ideology Is Losing Lives 515 
savagery, but only if money or incentives are involved.  Kass recognized the 
major inconsistency in the philosophical issue with organ commodification: 
Everyone is allowed to profit from an organ donation except the donor.29  
Kass posed the question: “Why . . . should everyone be making money from 
this business except the person whose organ makes it possible?”30  Kass 
hypothesized that there must be an innate “uneasiness” with organ 
transplantation, or else, “what would be objectionable about its turning a 
profit?”31 
There is a moral inconsistency involved in organ transplantation.  The 
act itself is not outlawed until compensation is involved.  Prostitution, 
another act that changes in moral character once money is introduced, is not 
banned or prohibited to the same degree as organ selling and is legal in many 
places.  Yet, prostitution does not lead to lifesaving results like the sale of 
organs does.  Furthermore, taking organs from cadavers is engrained in 
current organ transplant policies, and it is supported by the WHO.32  But 
harvesting organs from the dead could be condemned as defiling corpses 
while the bodies are still warm. 
Current international systems see organ donations from volunteers as 
acts of kindness, and not only applaud and admire this generosity, but, in 
some situations, expect it.  A father who refuses to give a kidney to his dying 
son, for no reason other than he chooses not to, would be viewed with scorn 
based on social norms.  Yet, a father who would sell his kidney in exchange 
for enough money to provide for his family is not only barred by law from 
doing so, but is also subject to social disdain, just like the uncaring father 
mentioned earlier.  Providing an organ is considered illegal and immoral 
when the exchange is made for money or other incentives, but why is it 
repulsive when the one who is giving up the most is compensated for their 
loss? 
History has taught us that societal values change, and what is considered 
unethical is not set in stone.  For example, life insurance was thought to be 
immoral until the mid-19th century.33  Princeton professor and renowned 
sociologist, Viviana Zelizer, once called the practice “a profanation,” 
because it “transformed the sacred event of death into a vulgar 
commodity.” 34   When viewed through a darker lens, life insurance is 
essentially a gamble that the insured will die prematurely, with a huge cash 
 
 29. Id. at 177. 
 30. Id. 
 31. Id. 
 32. WHO, supra note 1, at 2.  
 33. Stephen J. Dubner & Steven D. Levitt, Flesh Trade, N.Y. TIMES, July 9, 2006. 
 34. Id. 
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payout if one guesses right.35  However, the ethical scale shifts in both 
directions, as actions once deemed moral can become repulsive over time.  
Slavery is the best example of this shift — once an accepted practice, now 
prohibited worldwide.   
Not all countries share the same moral values.  Dog eating is accepted 
in some nations yet would cause riots in the United States.  Unmarried sexual 
activity is acceptable in some places, but harshly penalized in more 
traditional or religious-based communities.  Ultimately, morality arguments 
are weak due to their subjective nature.  People develop their standards of 
morality based on social, cultural, political, and scientific knowledge.  
Because of medical advancements in organ transplantation, the once 
unobtainable goal of increasing the volume of transplants is now well within 
the medical fields reach.36  It is time for the morality argument for purely 
altruistic organ donation systems to be re-evaluated.  
 
B. Organ Trafficking and the Black Market 
 
The strongest justification for prohibiting the sale of organs stems from 
the belief that legalization will enable rich people, or nations, to exploit the 
poor.  The argument is that financial incentives will put vulnerable 
demographics at the mercy of those ready to prey on their desperation.  
However, exploitation of marginalized communities is already occurring in 
the illegal organ market.  An international black market does exist, and it 
resides in the shady underbelly of our global society.  Implementing 
transplantation systems that would legally compensate organ providers 
would reduce the need for the existing black market.   
“Trafficking in organs” is the general term used to describe “illicit 
activities that aim to commercialize human organs and tissues that are 
needed for therapeutic transplantation.”37  Illegal organ trafficking can take 
many forms: trafficking in human beings for organ removal, organ tourism 
(or transplant tourism), or outright trafficking in organs, tissues and cells.38  
The illegal organ market is big business, with illegal transplantations being 
performed in around 100 countries.39  The WHO reported that between five 
to ten percent of organ transplants worldwide were performed illegally in 
 
 35. Id. 
 36. Dubner, supra note 33. 
 37. European Parliament, supra note 6, at 16.  
 38. Id. at 16-18.  
 39. UNODC, supra note 21, at 7. 
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2007.40  In 2011 alone, the illegal organ trade generated anywhere from 600 
million to 1.2 billion U.S. dollars.41   
Illegal organ trafficking first appeared in the 1980s, as foreign patients 
purchased organs from providers in India, with doctors from the Gulf States 
performing the operations.42  Initially, trafficking only occurred in India and 
some nations in South Asia, but the practice has spread, and traffickers are 
now targeting potential donors around the world. 43   The European 
Parliament identified certain areas as more susceptible to illegal trafficking, 
including “Latin America, North Africa and other regions where the 
economic crisis alongside social and political instability create opportunities 
for traffickers.”44   
Like the organ shortage, organ trafficking is a global problem.  But 
make no mistake, they are not two sides of the same coin — the organ 
shortage fuels the illegal organ market causing the proliferation of human 
trafficking.  The European Parliament reported, “[t]here is no doubt that the 
resulting structural shortage of legally obtained organs is the main cause of 
trafficking in organs.”45  As time runs out for those on organ transplant 
waiting lists, it is only natural that patients look to the black market.  The 
shortage of legally available organs has led to the rise of the illegal organ 
market, and the demand for illegal organs has caused the current upsurge in 
organ trafficking.46   
The illegal organ market is unregulated and provides no protection for 
patients or providers.  To combat the trafficking of organs, nations have tried 
to raise awareness of human trafficking, and passed legislation to monitor 
national organ donations and transplants.47  These preventative measures are 
weak and ineffective, because they do nothing to address the root of the 
problem — the overwhelming demand for organs.  The illegal organ market 
allows patients who can afford to pay, and are willing to accept the risks, to 
secure an organ that an altruistic system may have never rendered.  Even 
when an organ is secured, both the provider and the patient are at the mercy 
of unscrupulous brokers who facilitate the transaction.48   
 
 40. Id. at 11.  
 41. Id. 
 42. Id. 
 43. European Parliament, supra note 6, at 13. 
 44. Id. at 8.  
 45. Id. at 16. 
 46. Id.  
 47. UNODC, supra note 21, at 46-50.  
 48. Calandrillo, supra note 4, at 102. 
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The global prohibition on legal organ sales has, in essence, created a 
dual system for transplantation.  There is the legal altruistic system, and the 
illegal system, which serves as a de facto marketplace in some nations.49  
China and India have well known markets for organs, despite such 
transactions being expressly banned.50  As long as the demand is there, organ 
sales will continue in the unregulated black market.  If governments are truly 
interested in protecting at-risk communities from human trafficking, they 
must bring the market into the open.   
Aside from the harmful impacts of the criminal organ market, the notion 
that prohibiting organ providers from being compensated protects 
impoverished communities is questionable.  The reality is that the current 
organ shortage disproportionately affects developing countries, particularly 
patients who are oppressed by crippling poverty51 — the disproportional 
effect of the organ crisis is further examined in Section IV (A).  While 
wealthy patients can use the black market to find an illegal organ for 
transplantation, poor patients do not have the same luxury.  Government 
intervention is needed to ensure that all patients have equal access to life 
saving organ transplantations.52 
Before discussing alternatives to altruistic transplantation systems, it is 
worthwhile to examine the shortcomings of altruism in the United States, 
and the complex social and legal dilemmas that surround organ prohibition 
in the land of freedom. 
 
III. The Legal Rights Attached to the Human Body in the United 
States 
 
As patients continue to die unnecessarily, governments are slowly 
becoming more receptive to alternatives to the current altruistic systems in 
place.53  While the international community continues to drag its feet, change 
could be just one nation away.  One prominent nation shifting away from a 
purely altruistic organ donation system could lead other nations to follow 
suit.  The United States is the most logical nation to start a policy revolution, 
 
 49. Jingwei, supra note 3, at 10, 11. 
 50. Id. at 5. 
 51. William G. Couser et al., The Contribution of Chronic Kidney Disease to the Global 
Burden of Major Noncommunicable Diseases, 80 KIDNEY INTERNATIONAL 1258, 1260 (2011).  
 52. Calandrillo, supra note 4, at 101. 
 53. Organ Trafficking and Transplantation Pose New Challenges, 82 BULLETIN OF THE 
WORLD HEALTH ORG. 9 (2004), http://www.who.int/bulletin/volumes/82/9/feature0904/en/.   
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as it is a leader in transplantation surgeries and medical innovation yet still 
severely impacted by the organ shortage crisis. 
 
A. Why the United States and What Obstacles Are in the Way? 
 
The first successful organ transplant occurred in the United States in 
1954, when Dr. Joseph Murray and his team performed a kidney transplant 
between two twin brothers.54  This breakthrough changed the landscape of 
medicine.  Organ transplantation is now an accepted part of medicine, and 
the United States performs a staggering number each year.  In 2015, the 
United States accounted for nearly twenty-five percent of recorded organ 
transplants worldwide.55  However, despite reaching a new record high for 
transplantations in each of the last four years — a twenty percent increase in 
transplants from 2012 to 2016 — the national waiting list is well over three 
times the number of annual transplants. 56   The medical community is 
beginning to question the merits of an exclusively altruistic system as the 
organ shortage continues to claim more lives — despite the fact that the total 
number of living organ donations has increased every year since 2012.57   
In the United States, the altruistic organ transplantation system is held 
in place by two key statutes: the Uniform Anatomical Gift Act (UAGA)58 
and the National Organ Transplant Act (NOTA). 59   Due to scientific 
advancements in transplantations in the 1960s, the United States adopted the 
first Uniform Anatomical Gift Act in 1968.60  UAGA gave citizens the right 
to donate organs, eyes and tissue, which had never been established before.61  
Once immunosuppressive drugs were developed, there was a rise in 
 
 54. Anthony Komaroff, Remembering Dr. Joseph Murray, A Surgeon Who Changed the 
World of Medicine, HARVARD HEALTH PUBLISHING, (Nov. 28, 2012), https://www.health. 
harvard.edu/blog/remembering-dr-joseph-murray-a-surgeon-who-changed-the-world-of-me 
dicine-201211285590. 
 55. See Organ Donation and Transplantation Activities 2015, supra note 6; UNITED 
NETWOK FOR ORGAN SHARING, https://unos.org/about/annual-report/2015-annual-report/ (last 
visited Mar. 23, 2018).   
 56. Susan Scutti, U.S. Organ Transplants Increased Nearly 20 Percent in Five Years, 
CNN, (Jan. 9, 2017, 2:02 PM), https://www.cnn.com/2017/01/09/health/organ-donation-
2016/.   
 57. Organ Procurement & Transplantation Network, supra note 2.  
 58. UNIF. ANATOMICAL GIFT ACT § 1 (UNIF. LAW COMM’N 2006). 
 59. 42 U.S.C.S. § 274e (LEXISNEXIS through PL 115-132). 
 60. UNIF. ANATOMICAL GIFT ACT PREFATORY NOTE (LEXIS amended 2009). 
 61. Id.  
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successful transplantations, causing an increase in the demand for organs.62  
UAGA was revised in 1987 to account for the proliferation of 
transplantations, but the contents remained similar to the original act.63  In 
2006, UAGA was again revised to expand the scope of possible organ 
donors.64   
While UAGA defines who can provide an organ as an anatomical gift 
and legalizes organ donations as long as they are altruistic acts, the National 
Organ Transplant Act of 1984 expressly prohibits the sale or purchasing of 
organs for transplantation.  Under NOTA, once an organ donation is no 
longer a gift, the act becomes criminal.  The passage of NOTA was a 
response to a proposal by H. Barry Jacobs, an entrepreneurial physician, to 
create an organ brokerage system, called the “International Kidney 
Exchange.”65  At the time, nearly 20,000 people with organs suitable for 
transplantation were dying each year, but only around fifteen percent of those 
organs were being recovered for transplant.66  Dr. Jacobs proposed that the 
United States compensate organ donors, thus helping to address the organ 
shortage. 67   However, Congress disagreed, and quickly passed NOTA, 
maintaining that organ procurement should remain a “gift.”68  NOTA states, 
“[i]t shall be unlawful for any person to knowingly acquire, receive, or 
otherwise transfer any human organ for valuable consideration for use in 
human transplantation if the transfer affects interstate commerce.”69   
Since its inception, NOTA has been amended to encourage more organ 
transplants.  After amendment in 2008, NOTA no longer banned paired 
organ donations.70   In addition, NOTA permits compensating donors of 
renewable tissues, such as blood, sperm, and eggs.71  Oddly, eggs are not 
regenerable, but only one state does not allow the sale of a woman’s eggs.72  
NOTA’s exception for renewable tissues was the catalyst for the Ninth 
Circuit case Flynn v. Holder, which resulted in the allowance of bone 
 
 62. Id. 
 63. Id. 
 64. Id. 
 65. Calandrillo, supra note 4, at 79.   
 66. Id.  
 67. Id.  
 68. Id. at 79.   
 69. National Organ Transplant Act, Pub. L. No. 98-507, 98 Stat. 2346-2347 (1984). 
 70. John A. Robertson, Paid Organ Donations and the Constitutionality of the National 
Organ Transplant Act, 40 HASTINGS CONST. L.Q. 221, 224 (2013). 
 71. Id. at 223.   
 72. Id. at 232. 
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marrow donors to be compensated.73  Bone marrow is a regenerable tissue, 
yet it is still banned by NOTA, causing even more confusion regarding 
NOTA’s definition of an “organ.”74  
NOTA’s reference to “interstate commerce” might appear to suggest 
that NOTA is supported by the Constitution through the Commerce Clause.  
This seems like a stretch, given that the text of NOTA primarily involves 
organ procurement and monitoring transplantation data.  Assuming for the 
sake of this analysis that the Commerce Clause will not save NOTA from a 
constitutional challenge, the question remains: is NOTA unconstitutional?  
Unfortunately, there is no easy answer, because the law provides no clear 
definition of what rights people have over their own bodies.  
 
B. The Constitutionality of NOTA 
 
Radhika Rao, a professor at the University of California, Hastings 
College of the Law — who currently serves on the California Human 
Embryonic Stem Cell Research Advisory Committee and is a former 
member of the California Advisory Committee on Human Cloning — 
outlined the complexities of legal rights when applied to the human body in 
her article, “Genes and Spleens: Property, Contract, or Privacy Rights in the 
Human Body?”75   Professor Rao explained that there is “confusion and 
chaos” surrounding the legal status of the body, because there is no legal 
consensus on what rights are attached to the human body.76  Professor Rao 
stated, “[s]ometimes the body is treated as an object of property, sometimes 
it is dealt with under the rubric of contract, and sometimes it is not conceived 
as property at all, but rather as a subject of privacy rights.”77   
Common sense leads us to believe that our bodies are our own, and that 
no third party, including the government, should be able to usurp control.  
However, this right to bodily autonomy falls within the fundamental right to 
privacy, not property, because “bodily privacy is generally inalienable and 
unassailable.” 78   Sonia M. Suter, a professor at George Washington 
University Law School and a distinguished scholar on legal issues 
surrounding genetic material, explained the legal distinction between privacy 
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and property rights in her article, “Disentangling Privacy from Property: 
Toward a Deeper Understanding of Genetic Privacy.”79  Professor Suter 
clarified that property rights “connote control within the marketplace” and 
over something that is alienable from the person.80  In comparison, privacy 
rights entail “control over access to the self as well as things close to, 
intimately connected to, and about the self.”81   
The debate regarding the legal rights associated with the human body is 
outside the scope of this analysis, and the topic is explored in a large number 
of writings in academia.  For the purposes of this analysis, the focus is NOTA 
and what rights it impacts.  NOTA’s primary function is to prohibit the sale 
of organs in the United States, not to limit or define organ donations, which 
the UAGA covers.  Professor Suter stated that property rights involve 
“control within the market,” meaning “the ability to buy and sell the object 
as a commodity.”82  Privacy rights are not expressly implicated by NOTA, 
because a privacy analysis “treats the body as integrally connected to the 
person.”83  By nature, organ commodification involves the separation of 
organs from the person, and treats the organ as a separate part of the donor, 
not the whole person.84 
Due to NOTA, the United States strictly adheres to an altruistic organ 
transplantation system, which prevents donors from being compensated for 
their organs.  NOTA involves the commercialization of organs, which 
implicates property rights.  The constitutionality of NOTA hinges on what 
the Fifth Amendment defines as property.  The Due Process Clause of the 
Fifth Amendment protects American citizens from federal overreach, stating 
that the government may not deprive citizens of “life, liberty, or property, 
without due process of the law.”85  This begs the question: can a person claim 
that their body is legally their property? 
 
C. Is Your Body Your Property? 
 
The human body is and is not property, depending on who claims 
ownership.  Courts have been willing to find ownership when the body is 
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being used for a commercial purpose, like research.86  However, a person’s 
body is not their private property, because the body is not property.87  This 
confusing distinction is laid out in the marquee case for property rights in the 
body, Moore v. Regents of the University of California.88   
In Moore, John Moore (“Moore”) discovered that he had hairy-cell 
leukemia, and began receiving treatments from Dr. Golde (“Golde”) at the 
UCLA Medical Center.89  Moore needed to have his spleen removed, and 
consented to the operation.90  However, unbeknownst to Moore, Golde was 
aware that “certain blood products and blood components [of Moore’s 
spleen] were of great value in a number of commercial and scientific efforts,” 
and arranged to use parts of Moore’s removed spleen for research before the 
operation took place.91  Using Moore’s spleen, Golde created a cell line, 
named the “Mo cell line,”92 and patented the cell line before agreeing to 
commercially develop his work.93   
Moore later brought suit against Golde and the university, and the court 
found that Golde did breach his fiduciary duty by not informing Moore of 
his economic interest in Moore’s spleen.94  However, the court did not find 
that Golde was liable for conversion, which is “a tort that protects against 
interference with possessory and ownership interests in personal property.”95  
Moore needed to have a property interest in his cells to go forward with a 
conversion claim, and the court was unwilling to extend ownership to 
Moore.96  The court ruled that once Moore’s cells left his body, he no longer 
had an ownership interest in them, because he did not expect the cells back.97  
Furthermore, after finding no case law to support Moore’s conversion claim, 
the court added: 
We do not find this surprising, since the laws governing such things as 
human tissues, transplantable organs, blood, fetuses, pituitary glands, 
corneal tissue, and dead bodies deal with human biological materials as 
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objects of sui generis, regulating their disposition to achieve policy goals 
rather than abandoning them to general law of personal property.98   
The rulings in two later cases, Greenberg v. Miami Children’s 
Hospital99 and Washington University v. Catalona,100 further elaborated on 
the difference between commercial property ownership and personal 
property interests in one’s own body.101  In Greenberg, the plaintiffs were 
the parents of children afflicted with Canavan disease, a rare, and fatal, 
genetic disorder that frequently occurs in Ashkenazi Jewish families.102  The 
plaintiffs had approached Matalon and asked him to discover the gene 
responsible for the Canavan disease.103  To further this end, they voluntarily 
provided Matalon with a vast supply of blood and tissue samples.  Matalon 
eventually isolated the Canavan disease in 1993. 104   However, without 
informing the plaintiffs, Matalon proceeded to patent the gene and related 
research, and restricted access to his research.105  The plaintiffs sued Dr. 
Matelon and the Miami Children’s Hospital.106  
The court relied heavily on Moore, finding that the plaintiffs voluntarily 
gave genetic material to Matalon for research, and that the genetic material 
did not qualify as property. 107   Only when the isolated gene was 
commercialized did the genetic material become property, which supported 
Matalon’s claim of ownership and right to patent his research. 108   Dr. 
Matalon did not have a duty to inform the Greenbergs of his patent, because 
Matalon’s role was that of a researcher, not a physician. 109   Although 
Matalon’s actions ran contrary to the wishes of the plaintiffs, whose 
biological material allowed the research to go forward, the court ruled that 
the donors held no property rights in the donated materials.110  The court 
stated, “the property right in blood and tissue samples evaporates once the 
sample is voluntarily given to a third party.”111 
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In Washington University v. Catalona, the district court stated that 
genetic material was not just the property of the researchers after it had been 
commercialized, but that the original material was the property of the 
researchers, not the donors. 112   Washington University (“WU”) sued its 
former employee, Dr. William Catalona, and his patients, who had agreed to 
participate in one or more of Dr. Catalona’s research projects while he was 
working at WU. 113   Catalona was a respected surgeon and medical 
researcher, and he was pivotal in establishing the GU Biorepository, which 
housed biological samples for prostate cancer research. 114   Catalona’s 
patients were asked to sign informed consent forms to allow Catalona to use 
their biological material for cancer research.115  The forms allowed patients 
to discontinue participation and withdraw their consent.116  In 2003, Catalona 
accepted a position at another university, and had his patients sign a release 
form allowing their genetic material to be transferred with Dr. Catalona.117   
WU filed for a declaratory judgment to stop Catalona from transferring 
the biological materials out of the GU Repository, which was housed in a 
WU owned building.118  Both WU and the patients who had supplied the 
biological materials claimed ownership, but the court ruled in favor of 
WU.119   The court held that, “plaintiff Washington University owns all 
biological materials . . . in the GU Repository,” and, “neither Dr. William 
Catalona nor any research participant . . . has any ownership or proprietary 
interest in the biological samples housed in the GU Repository.”120  Based 
on the language in the informed consent forms, participants gave their 
biological materials as a “gift,” thus relinquishing any possessory interest.121  
Despite the biological materials not having been used for research or 
developed for commercial use yet, the court granted ownership of the 
biological materials to WU, because participants were not allowed to 
withdraw their consent for already delivered materials.122  
A consistent theme in Moore, Greenberg, and Catalona, was concern 
for how medical research might be influenced by the courts’ decisions.  In 
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Greenberg, the court feared that granting donors possessory interests in their 
genetic material “would cripple medical research.”123  The court in Catalona 
expressed concern about the ramifications of allowing patients to dictate how 
and where their biological samples were used.124  The court theorized that 
patients might abuse this power, like a blood donor dictating to whom his or 
her blood could be donated based-on ethnicity or gender.125  The court stated, 
“This kind of ‘selectiveness’ is repugnant to any ethical code which 
promotes medical research to help all mankind.”126   
Concern that medical advancement will be harmed is understandable, 
but the courts’ fear has caused them to manipulate settled property law.  
Justice Broussard’s dissent in Moore theorized that the majority did not 
intend to suggest “that a removed body part, by its nature, may never 
constitute ‘property.’”127  Hypothetically, Justice Broussard stated that if a 
drug company broke into UCLA Medical Center and stole Dr. Goude’s Mo-
cell line, the cells would be considered stolen property.128  Professor Rao 
analogized the treatment of body parts to the legal status of animals, water, 
and other natural resources.129  Professor Rao explained that because “body 
parts are free for appropriation by the scientists who transform them into 
useful products,” the human body is treated as “a form of property that 
belongs to no one and is part of the public domain.”130  However, treating 
body parts as a natural resource is illogical, because the source of a body part 
is always a person.  All human biological material was at some point a part 
of a person, and taking this material is not the same as drawing water from a 
stream or mining coal from the ground.131   
In sum, the legal status of the human body is in disarray partly due to 
the public policy rationale that property interests of donors should not hinder 
medical research.  If the Supreme Court of the United States were to affirm 
this policy argument in a future case, it would be much easier to comprehend 
the distinction between the possessory interest of researchers and 
individuals.  As it stands, it would be difficult to challenge NOTA as 
unconstitutionally restricting property rights.  NOTA, however, is a statute 
created by Congress, and a constitutional challenge is not the only way to 
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strike it down.  The legislature can amend or eliminate NOTA, and, in light 
of the growing unrest over the failure of the nation’s current altruistic 
transplantation system, change may be inevitable.   
 
D. Public Opinion Is Shifting Away from NOTA 
 
Former Congressman Al Gore initially introduced NOTA for the 
purpose of keeping organ donations an act of kindness rather than for a profit, 
fearing that commercializing organs would only benefit wealthy Americans, 
and leave poor communities open to exploitation.132  As outlined earlier, this 
is still a key argument for those in favor of preserving the current altruistic 
system in the United States.  However, this argument overlooks the very real 
ramifications of NOTA’s prohibition.  The government claims to have 
created NOTA to ensure the wealthy were not given greater access to organ 
transplantations than the poor, but in a country with no universal health 
insurance, this motive seems insincere.133  The organ shortage in the United 
States is so severe that an estimated three hundred Americans travel abroad 
each year to purchase an organ, subjecting themselves to the dangers of the 
black market.134  Growing numbers in the medical community are beginning 
to push for reform. 
In October of 2014, thirty years after the creation of NOTA, 135  a 
distinguished group of scholars and medical professionals in the United 
States wrote an open letter regarding kidney transplantation to President 
Barack Obama, Secretary of Health and Human Services Sylvia Mathews 
Burwell, Attorney General Eric Holder and leaders of Congress.136  The 
letter was a call for action, detailing how the current policy on organ 
donations was not working, and that the government was incorrect in its 
“unsubstantiated assumption” that providing benefits to organ donors would 
inevitably lead to donors “being exploited or coerced.” 137   The letter 
advocated for “the swift initiation of evidenced-based research on ways to 
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offer benefits to organ donors in order to expand the availability of 
transplants.”138 
The open letter outlined the inadequacy of the current policy on organ 
transplants, and specifically detailed the systems failure in regard to kidney 
transplants.139  Not only would more kidney transplants save lives, but it 
would also alleviate a huge financial burden on the United States health care 
system.  Seven percent of Medicare’s annual budget was spent on patients 
suffering from kidney failure.140  Each kidney transplant, however, saved 
Medicare over $100,000 USD when compared to the cost of dialysis 
treatments.141  From 2009 to 2014, despite efforts to reduce the wait time for 
a kidney transplant, the average waiting period increased by a year and a 
half.142  In the face of growing expenses, mounting deaths, and with no end 
in sight, the letter pleaded for the government to begin looking at non-
altruism based policies.  Aside from cash incentives and free health care, the 
letter also stated, “Additional benefits such as a pension contribution, tax 
credit, or charitable contributions in the donors’ names should also be 
explored, particularly when those benefits will appeal to donors across the 
financial spectrum.”143  Post-altruistic policies should focus on how to entice 
all Americans to become donors, because, “Giving an organ need not fall 
disproportionately on people with lower incomes.”144 
Not only is the current system not working, it isn’t fair.  Adhering to 
altruism is only required of the organ supplier.145  Kenneth Newell, a former 
president of the American Society of Transplantation and a current transplant 
surgeon at Emory University, bluntly explained the reality of the United 
States system: “As a surgeon, I get paid…  The hospital gets paid.  The 
nephrologist gets paid.  The patient gets a new kidney and perhaps gets to 
re-engage in his life’s work.  The insurer gets money…  Everyone gets paid, 
except the donor.” 146   Preserving an unfair and inefficient system will 
exacerbate the already dire organ shortage.  As more Americans each year 
find they need an organ transplant themselves, or have someone in their lives 
 
 138. Id. 
 139. Id. 
 140. Id. 
 141. Id. 
 142. Id. 
 143. Id. 
 144. Id.  
 145. Tina Rosenberg, It’s Time to Compensate Kidney Donors, N.Y. TIMES, (Aug. 7, 2015, 
5:15 AM), https://opinionator.blogs.nytimes.com/2015/08/07/its-time-to-compensate-kidne 
y-donors/.  
 146. Id. 
   
Summer 2019]          Organ Donations: Why the Gift of Life Ideology Is Losing Lives 529 
who needs one, people will begin to grasp the reality of the situation and 
push for change.  The medical community sees the tipping point coming, yet 
the legislature continues to hide behind NOTA.   
The organ crisis presents a complex ethical, political, and legal dilemma 
in the United States.  However, as stated earlier, the issues that the United 
States must overcome are apparent in other countries as well because the 
organ shortage is a global problem.  Every nation deals with similar and 
distinct problems regarding organ transplantation.  Though creating a 
uniform organ transplantation system, adopted and enforced by all nations, 
is unfeasible at this time, the global community can begin to make 
progressive policy decisions to alleviate the damage caused by the organ 
crisis.   
 
IV.  Modern Organ Transplantation Policies to Meet  
Global Demand 
 
International policies will not shift away from purely altruistic systems 
overnight.  Proper preparation and planning will be necessary for future 
organ transplantation systems, in order to ensure that the problems of the 
illegal organ market do not root themselves in new systems.  As outlined 
above, while more medical professionals have begun to promote the sale and 
purchasing of organs, strong support for current altruistic policies remain.  
However, as policy makers grapple with arguments for and against continued 
adherence to the altruistic system, the organ deficit will continue to expand, 
and more people on waiting lists will be forced to wait helplessly for a 
miracle or death.   
The solution to the global organ crisis does not need to be an all-or-
nothing policy shift.  Allowing even one organ to escape the restrictions of 
altruistic policies would drastically decrease the number of fatalities.  Data 
has shown that the demand for kidney transplants alone dwarfs the demand 
for all other organs combined.  Kidneys are the starting point for post-
altruism-based systems.  By focusing on alleviating the growing demand for 
kidneys, whether through monetarily compensating kidney providers, or 
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A. Kidney Transplantations by the Numbers 
 
Kidney transplants are the most frequently performed organ transplants 
in the world.147  Kidneys are unique organs, because, while people are born 
with two kidneys, only one healthy kidney is necessary to sustain life.148  One 
healthy kidney can replace two diseased kidneys, making living donations a 
viable option.149  The kidney’s job is to filter excess waste and fluid that has 
built up in the bloodstream.150  If a person suffers from End-Stage Renal 
Disease (ESRD), commonly referred to as kidney failure, that patient 
requires renal replacement therapy.  There are only two medical procedures 
a patient can seek: dialysis and a kidney transplant.151  Dialysis can prolong 
a patient’s life, but the treatment will never restore the health of the kidney.  
A patient receiving dialysis treatments will need to remain on dialysis for 
life.  For those with kidney failure who hope to regain a sense of normalcy 
in their lives, receiving a kidney transplant is the only solution. 
Kidney failure develops from chronic kidney disease (CKD).152  CKD 
has seen a worldwide increase in the last decade, and is expected to become 
dramatically more prevalent in developed countries in the next few 
decades.153  In addition, the majority of people with CKD do not realize they 
have it, because there are few symptoms in the early stages of the disease.154  
CKD may not be discovered until kidney function is substantially 
impaired.155  Kidney disease is caused by a number of factors, but the largest 
contributors are hypertension and diabetes.156  Hypertension can cause and 
accelerate the decay of one’s kidneys, and it is also a consequence of chronic 
kidney disease and kidney failure.157  In developing countries, kidney failure 
is linked to hypertension or diabetes in fifty-one percent of cases.158  In the 
most developed countries, forty-five percent of patients suffering from 
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kidney failure also have diabetes. 159   Unfortunately, the proliferation of 
diabetes does not appear to be slowing down.  Over the past twenty-five 
years, the number of Americans with type 2 diabetes has nearly doubled.160  
The situation is even worse in Asia, where type 2 diabetes rates have 
increased an estimated “three- to fivefold in India, Indonesia, China, Korea, 
and Thailand.”161 
The global organ shortage is driven by the need for kidney 
transplants. 162   In 2014, an estimated 84,347 kidney transplants were 
performed globally, which made up nearly sixty-seven percent of all organ 
transplants for that year.163  In addition, 41.8 percent of kidney transplants 
came from living donors, with living donors far exceeding cadaver organs in 
Africa, Eastern Mediterranean, and South East Asia.164  It is estimated that 
around two million people worldwide suffer from kidney failure, but this 
figure may represent only ten percent of the number of people who actually 
need renal replacement therapy. 165   The United States has a staggering 
95,300 people on the national kidney transplant waiting list, making up over 
82 percent of the total organ waiting list.166  In 2017, approximately fifty-
seven percent of organ transplants were kidneys (a little over 19,000 
surgeries).167  In 2013, the European Union, including Turkey, Iceland, and 
Norway, added 70,000 people to the kidney transplant waiting list, despite 
performing twenty-nine percent of global kidney transplants the previous 
year.168 
Data regarding kidney failure and transplantation shows a dark disparity 
between developed and developing countries.  In 112 developing countries, 
made up of over 600 million people, an estimated one million people die 
each year from untreated kidney failure.169  Because of the high cost of renal 
replacement therapy, the majority of the estimated two million people who 
need dialysis or a kidney transplant receive it in one of five countries: United 
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States, Japan, Germany, Brazil, and Italy.170  In the bottom fifty percent of 
the world’s population, only twenty percent of people suffering from kidney 
failure receive treatment.171  Developed countries have made treatment more 
accessible by expanding dialysis programs, and trying to make 
transplantation more available.172  Unfortunately, for those in developing 
countries, kidney failure remains a death sentence.173  In addition, kidney 
donation data shows a trend of racial and gender bias.  For example, a study 
in India showed that females were the donors in sixty-six percent of kidney 
transplantations but were recipients only seventeen percent of the time.174  
Moreover, in the United States, the organ shortage disproportionately 
disadvantages minorities.  People of color comprise over forty percent of 
those on the national waiting list, and account for more than half of the 
deaths.175  The fear that moving away from altruistic donation policies will 
lead to exploitation of impoverished and marginalized people is blind to the 
fact that these people are already feeling the brunt of the ongoing organ 
crisis.   
 
B. Legalizing Kidney Transactions 
 
Altruistic organ transplantation systems have failed to meet the demand 
for organs, creating the current highly lucrative illegal organ market.  The 
foundation of any marketplace is supply and demand, and the black market 
is only allowed to thrive because the legal supply is incapable of meeting the 
need for organs.  International organ transplantation systems must adapt to 
the current crisis, and one potential life-saving solution would be for 
countries to create national kidney markets.   
The black-market deals extensively in illegal kidneys because it is not 
necessary to kill someone to obtain one of their kidneys, although people are 
sadly still murdered for their organs.  Unscrupulous organ brokers, the 
middlemen between desperate parties, use cash payouts, deceit, and violence 
to obtain organs, and target poor and desperate people already marginalized 
by society and poverty.176  In Pakistan, for example, most voluntary donors 
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receive half the compensations they were originally promised by black 
market brokers.177   
Regulation and legalization will stop black market exploitation and help 
disseminate critical information regarding kidney donations to potential 
donors.  Much like the legalization of marijuana in the United States, nations 
will need to establish policies and regulations regarding the sale of 
kidneys. 178   An overarching international organization, whether it is an 
existing entity or a newly formed one, could establish rules and regulations 
to ensure safety and fairness to all parties who wish to participate.  
Compensating kidney donors is the foundation that countries can build upon 
to create new transplantation systems and lessen the demand for organs that 
fuels the illegal market.  Fortunately, Iran has had a functioning kidney 
market since 1988, which can be studied as a possible model for other nations 
moving forward. 
 
C. Middle Ground Between Altruism and Commercialization –  
The Iranian System of Kidney Transplantation 
 
The first kidney transplant in Iran was performed in 1967, and over the 
next eighteen years approximately 100 total transplantations occurred.179  
From 1985 to 1987, the number of transplantations exploded due to the 
construction of two transplantation centers.  During that span, 274 
transplantations were performed,180 and all the kidneys came from living 
relative donors. 181   However, the national kidney transplant waiting list 
continued to swell, because Iran had not yet established a deceased donor 
program, and patients who could not secure a kidney from a relative were 
left with no options for transplantation.182  
In 1988, Iran implemented a “government funded, regulated, and 
compensated living-unrelated donor renal transplantation program.”183  By 
1999, there were no patients on the national waiting list.  By 2005, seventy-
eight percent of kidney transplants performed in Iran were from living-
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unrelated donors.184  Patients are referred to the Dialysis and Transplant 
Patients Association (DATPA), where they are matched with unrelated 
donors, removing any need for a broker or agent.185  The transplants are 
performed at university hospitals and the government pays for all medical 
costs.186  Donors receive the equivalent of $1,200 USD, medical insurance 
and immunosuppressive drugs paid for by the government or charitable 
organizations.187  In addition, sellers often receive a “rewarding gift” from 
the recipient, or from a charitable organization if the recipient is too poor to 
afford a gift.188  The system is closely overseen by the Iranian Society for 
Organ Transplantation.189  
Based on the Iranian system, allowing the sale and purchasing of organs 
would help the international community combat the growing organ deficit.  
However, commercializing organ transactions is not a miracle solution, and 
the Iranian system has its flaws. 190   The Iranian system has poor post-
operation follow up protocols for organ providers and recipients.191  Also, 
illegal activities have still found their way into the government operated 
system.  Despite eliminating the national waiting list, transplantations still 
usually take about a year to be arranged, and rich Iranians often work with 
brokers to bypass this delay.192  However, the purpose of analyzing the 
Iranian system is not to promote it as the perfect solution, but as a functional 
supplement to an exclusively altruistic system.  Like the open letter to 
President Obama advised, nations need to begin gathering data about 
alternative organ transplantation systems.  At this point, there is no agreed 
upon transplant system that all nations would adopt.  What is known is that 
current altruistic systems do not work because people continue to die waiting 
for organs to become available for transplantation.   
If organ transplantation systems were viewed on a spectrum, altruistic 
donation would be on one end and commercial procurement of organs at the 
other.  While Iran is still the only nation to legalize the sale of kidneys,193 
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other nations are beginning to explore options in between altruism and 
commercialization.  Two systems within the middle of the spectrum have 
emerged that warrant serious consideration.  Some nations are beginning to 
implement reimbursement programs for kidney providers to ease their 
financial burden, while other nations are creating opt-out organ donation 
programs to facilitate more organ recovery from cadavers. 
 
D. Reimbursement Programs 
 
A study published in the American Journal of Transplantation, reported 
that in 2009, twenty-one countries had implemented some kind of 
reimbursement program for living organ donors.194  These reimbursement 
programs target five major types of cost that are incurred by organ donors: 
travel, accommodations, meals, lost income, and childcare.195  Of the twenty-
one countries with reimbursement programs, the majority only reimbursed 
donors for travel, lost wages, and accommodations.196  Only ten countries 
had comprehensive programs that addressed all five major costs in some 
capacity.197  Reimbursements are covered in a variety of ways, including 
through insurance, charitable organizations, and government funds.198  In 
some nations, like the United Kingdom, lost wages are covered by the organ 
provider’s employer, through sick or paid leave.199 
The Health Minister of Australia, Tanya Plibersek, made it clear that 
Australia would never endorse the sale of organs, but supports providing 
some financial relief to kidney providers.200  Kidney providers are not given 
monetary payments, but the government does provide a donor with up to six 
weeks paid leave.201  Other nations, like Saudi Arabia and Israel, offer long-
term health and life insurance, along with other creative incentives.202  Saudi 
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Arabia provides a ticket discount on national airlines for kidney donors, 
while Israel offers donors free entrance to national parks.203   
Internationally, there is an accepted distinction between reimbursing 
living organ donors and providing compensation that results in financial gain 
for organ providers — the latter is still illegal internationally.  In 2008, the 
Declaration of Istanbul on Organ Trafficking and Transplant Tourism, the 
European Parliament, and the Asian Taskforce on Organ Trafficking, each 
urged their respective member states to create avenues that allowed 
reimbursing living organ donors.204  Advocates for keeping organ donations 
strictly altruistic cannot deny that organ donations do require sacrifices aside 
from the actual organ.  Lessening the burden on organ donors does not 
necessarily contradict the values promoted by altruism.  The act of giving an 
organ is still, at its core, based on human kindness even in countries that have 
implemented reimbursement policies.   
 
E. Opt-in Programs 
 
Nations that refuse to consider any form of compensation for living 
organ donors, monetary or not, will need to look to cadavers to ease the 
pressure of the organ crisis.  Transplant organs removed from cadavers are 
highly regulated,205 and there is a great deal of international support for them.  
In 1999, a study in the United States showed roughly seventy five percent of 
Americans supported the idea of having their organs used for transplantation 
upon their death.206  However, only around twenty-five percent of Americans 
had actually registered to be organ donors.207  While individuals may support 
the concept of posthumous organ donations in theory, an underwhelming 
number of people actually take the necessary steps to become donors.  
In an article for the WHO Bulletin, University of Valparaiso Professor 
Alejandra Zuniga-Fajuri, Ph.D., detailed how some nations, including Chile, 
have enacted presumed consent legislation to increase the number of 
posthumous organ donations. 208   Presumed consent policies, or opt-out 
systems, presume an individual consents to donate their organs unless the 
individual expressly refuses to become a potential donor.209  Opt-in systems 
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require individuals to expressly consent to becoming donors.210  Countries 
that have opt-out systems have posthumous donation rates twenty-five to 
thirty percent higher than opt-in countries, although evidence shows that this 
increase is not entirely due to presumed consent policies.211  A number of 
countries have implemented opt-out policies, including Austria, Belgium, 
the Czech Republic, Finland, France, Greece, Hungary, Israel, Italy, Spain, 
Slovenia, Norway, Poland, Sweden, and Turkey.212  
In addition to presuming consent, some opt-out systems include a 
priority rule to determine priority for patients who need a transplant.213  In 
Singapore, an individual who expressly refuses to donate organs 
posthumously gives up priority for receiving an organ in the future.214  This 
opt-out system provides an incentive for individuals to not opt-out, because 
they are given priority if they need a transplant in the future.215  The opt-out 
system, with the priority rule, has caused an increase in posthumous organ 
donations in Singapore.216  Israel implemented a similar system in 2010, but 
with a much more complex priority system, involving donor cards, priority 
points, living organ donations, and different tiers of priority for future organ 
transplants.217  Since implementing this system, Israel has seen a significant 
increase in organ transplantations.218 
Professor Zuniga-Fajuri explained that giving priority to individuals 
who remain in opt-out donation systems is consistent with the values of 
altruism.  Professor Zuniga-Fajuri stated, “The principle is consistent with 
the view that a fair concept of justice calls for reciprocal altruism, because 
organs may be considered a scarce societal resource.”219  The priority rule 
might lead to fewer purely altruistic organ donations, but the purpose is not 
to commercialize organs.220  Rather, the priority rule aims to keep “free-
riders” from taking advantage of the system.221  It would be unfair if someone 
were willing to receive an organ through the opt-out system, yet refused to 
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be an organ donor posthumously.222  Professor Zuniga-Fajuri added that the 
goal of opt-out systems with priority rules is not to punish those who refuse 
to be donors, but to “prompt people who opted out of donor programmes to 
reconsider their choice.”223 
Like all other transplantation systems, the opt-out system has flaws.  
Chile’s opt-out system, enacted in 2010, got off to a rocky start due to 
misinformation.224  A survey showed that seventy percent of Chileans did 
not know the scope of the new system, and did not understand the details of 
the opt-out system.225  Of those surveyed, sixteen percent thought the system 
was regulated by the market, twelve percent thought that only wealthy 
individuals received organs for transplantation, and thirteen percent even 
believed that health-care providers would let patients die in order to harvest 
their organs.226  Because of this misinformation, 2,780,223 Chileans had 
opted out of the system by July 2012.227  To combat this, the government 
created a priority rule, and required future individuals who refused to be 
posthumous organ donors to provide a notarized statement expressly 
rejecting presumed consent.228  It is still too early to tell if the Chilean system 
will be successful,229 but what is important is Chile’s willingness to change 
its policies to remedy the shortage of organs available for transplantation.  
Only by trying alternatives to purely altruistic systems can the international 




The world needs more organs to become available for transplantation.  
Clearly, current altruistic systems, relying exclusively on human kindness, 
have not been able to provide enough organs to meet the growing demand.  
The best organ transplant system is the one that facilitates the most 
transplantations and saves the most lives.  The aversion to any semblance of 
body part commodification is not only resulting in unnecessary deaths, it is 
supporting a black market that is dangerous to organ providers and patients.  
Nations need to be proactive and explore different incentives to encourage 
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voluntary organ providers from all walks of life, not just poor communities.  
There may not be one model that will work for all countries, but whatever 
model a country chooses to adopt must ensure that there are sufficient organs 
available for anyone who needs one.   
Altruism can coexist with monetary compensation or other alternative 
inducements to donate.  People who choose to donate organs altruistically 
will continue to donate under new transplantation systems — incentives are 
for those who would not, or could not, otherwise donate their organs.  To 
maximize available organs, national policies must allow for altruistic donors, 
and non-altruistic organ providers.  Certainly, more people will be willing to 
donate their organs if the cost of the procedure, including lost wages and 
other related costs were reimbursed by the government or a charitable 
organization.  A straightforward, transparent, strictly regulated policy, 
applied fairly and evenly, would produce more organs for transplantation, 
and save countless lives.   
 
 
 
 
 
 
 
